These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 23567370)

  • 41. Does anxiety affect risk of dementia? Findings from the Caerphilly Prospective Study.
    Gallacher J; Bayer A; Fish M; Pickering J; Pedro S; Dunstan F; Ebrahim S; Ben-Shlomo Y
    Psychosom Med; 2009 Jul; 71(6):659-66. PubMed ID: 19553290
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia.
    Di Carlo A; Lamassa M; Baldereschi M; Inzitari M; Scafato E; Farchi G; Inzitari D
    Neurology; 2007 May; 68(22):1909-16. PubMed ID: 17536047
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of neuropsychiatric symptoms and their association with functional limitations in older adults in the United States: the aging, demographics, and memory study.
    Okura T; Plassman BL; Steffens DC; Llewellyn DJ; Potter GG; Langa KM
    J Am Geriatr Soc; 2010 Feb; 58(2):330-7. PubMed ID: 20374406
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.
    Lyketsos CG; Lopez O; Jones B; Fitzpatrick AL; Breitner J; DeKosky S
    JAMA; 2002 Sep; 288(12):1475-83. PubMed ID: 12243634
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence of dementia and cognitive impairment, not dementia in the United States.
    Plassman BL; Langa KM; McCammon RJ; Fisher GG; Potter GG; Burke JR; Steffens DC; Foster NL; Giordani B; Unverzagt FW; Welsh-Bohmer KA; Heeringa SG; Weir DR; Wallace RB
    Ann Neurol; 2011 Sep; 70(3):418-26. PubMed ID: 21425187
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia.
    de Medeiros K; Robert P; Gauthier S; Stella F; Politis A; Leoutsakos J; Taragano F; Kremer J; Brugnolo A; Porsteinsson AP; Geda YE; Brodaty H; Gazdag G; Cummings J; Lyketsos C
    Int Psychogeriatr; 2010 Sep; 22(6):984-94. PubMed ID: 20594384
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Course of neuropsychiatric symptoms in dementia: 5-year longitudinal study.
    Vik-Mo AO; Giil LM; Ballard C; Aarsland D
    Int J Geriatr Psychiatry; 2018 Oct; 33(10):1361-1369. PubMed ID: 29979473
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Severity of CIND and MCI predict incidence of dementia in an ischemic stroke cohort.
    Narasimhalu K; Ang S; De Silva DA; Wong MC; Chang HM; Chia KS; Auchus AP; Chen C
    Neurology; 2009 Dec; 73(22):1866-72. PubMed ID: 19949033
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuropsychiatric profiles of patients with Alzheimer's disease and vascular dementia in Taiwan.
    Hsieh CJ; Chang CC; Lin CC
    Int J Geriatr Psychiatry; 2009 Jun; 24(6):570-7. PubMed ID: 19051223
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.
    Hallikainen I; Hänninen T; Fraunberg M; Hongisto K; Välimäki T; Hiltunen A; Karppi P; Sivenius J; Soininen H; Koivisto AM;
    Int Psychogeriatr; 2013 Aug; 25(8):1335-44. PubMed ID: 23676340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The apolipoprotein E genotype predicts longitudinal transitions to mild cognitive impairment but not to Alzheimer's dementia: findings from a nationally representative study.
    Brainerd CJ; Reyna VF; Petersen RC; Smith GE; Kenney AE; Gross CJ; Taub ES; Plassman BL; Fisher GG
    Neuropsychology; 2013 Jan; 27(1):86-94. PubMed ID: 23356599
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trajectories and risk factors of dementia progression: a memory clinic cohort followed up to 3 years from diagnosis.
    Edwin TH; Strand BH; Persson K; Engedal K; Selbæk G; Knapskog AB
    Int Psychogeriatr; 2021 Aug; 33(8):779-789. PubMed ID: 33213607
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuropsychiatric symptoms in amnestic mild cognitive impairment: increased risk and faster progression to dementia.
    Somme J; Fernández-Martínez M; Molano A; Zarranz JJ
    Curr Alzheimer Res; 2013 Jan; 10(1):86-94. PubMed ID: 23016837
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcomes of cognitively impaired not demented at 2 years in the Canadian Cohort Study of Cognitive Impairment and Related Dementias.
    Hsiung GY; Donald A; Grand J; Black SE; Bouchard RW; Gauthier SG; Loy-English I; Hogan DB; Kertesz A; Rockwood K; Feldman HH
    Dement Geriatr Cogn Disord; 2006; 22(5-6):413-20. PubMed ID: 16966831
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuropsychiatric symptoms in 921 elderly subjects with dementia: a comparison between vascular and neurodegenerative types.
    Caputo M; Monastero R; Mariani E; Santucci A; Mangialasche F; Camarda R; Senin U; Mecocci P
    Acta Psychiatr Scand; 2008 Jun; 117(6):455-64. PubMed ID: 18363771
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Caregiver coping strategies predict cognitive and functional decline in dementia: the Cache County Dementia Progression Study.
    Tschanz JT; Piercy K; Corcoran CD; Fauth E; Norton MC; Rabins PV; Tschanz BT; Deberard MS; Snyder C; Smith C; Lee L; Lyketsos CG
    Am J Geriatr Psychiatry; 2013 Jan; 21(1):57-66. PubMed ID: 23290203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia.
    Fuh JL; Wang SJ; Cummings JL
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1337-41. PubMed ID: 16170072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuropsychiatric symptoms, APOE ε4, and the risk of incident dementia: a population-based study.
    Pink A; Stokin GB; Bartley MM; Roberts RO; Sochor O; Machulda MM; Krell-Roesch J; Knopman DS; Acosta JI; Christianson TJ; Pankratz VS; Mielke MM; Petersen RC; Geda YE
    Neurology; 2015 Mar; 84(9):935-43. PubMed ID: 25653291
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.
    Kashiwa Y; Kitabayashi Y; Narumoto J; Nakamura K; Ueda H; Fukui K
    Psychiatry Clin Neurosci; 2005 Dec; 59(6):697-704. PubMed ID: 16401246
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuropsychiatric Inventory in Community-Dwelling Older Adults with Mild Cognitive Impairment and Dementia.
    Nunes PV; Schwarzer MC; Leite REP; Ferretti-Rebustini REL; Pasqualucci CA; Nitrini R; Rodriguez RD; Nascimento CF; Oliveira KC; Grinberg LT; Jacob-Filho W; Lafer B; Suemoto CK
    J Alzheimers Dis; 2019; 68(2):669-678. PubMed ID: 30856109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.